Sheibani M, Ghasemi M, Dehpour A
Cells. 2022; 11(1).
PMID: 35011733
PMC: 8750948.
DOI: 10.3390/cells11010171.
Dziedzicka-Wasylewska M, Mackowiak M, Fijat K, Wedzony K
J Neural Transm (Vienna). 1996; 103(7):765-76.
PMID: 8872863
DOI: 10.1007/BF01273357.
Baptista T, Teneud L, Contreras Q, Burguera J, Burguera M, Hernandez L
J Neural Transm Gen Sect. 1993; 94(2):75-89.
PMID: 7509157
DOI: 10.1007/BF01245002.
Banay-Schwartz M, Wajda I, Manigault I, Deguzman T, Lajtha A
Neurochem Res. 1982; 7(2):179-89.
PMID: 7121707
DOI: 10.1007/BF00965056.
Ushijima I, Yamada K, Furukawa T
Psychopharmacology (Berl). 1982; 76(2):136-8.
PMID: 6805023
DOI: 10.1007/BF00435267.
Clinical and neuropathological aspects of long-term damage to the central nervous system after lithium medication.
PEIFFER J
Arch Psychiatr Nervenkr (1970). 1981; 231(1):41-60.
PMID: 6797383
DOI: 10.1007/BF00342829.
The effect of long-term concurrent administration of chlorpromazine and lithium on the striatal and frontal cortical dopamine metabolism in rats.
Eroglu L, Hizal A, KOYUNCUOGLU H
Psychopharmacology (Berl). 1981; 73(1):84-6.
PMID: 6785796
DOI: 10.1007/BF00431108.
Comparison of acute and chronic lithium treatment on 3H-norepinephrine uptake by rat brain slices.
Cameron O, Smith C
Psychopharmacology (Berl). 1980; 67(1):81-5.
PMID: 6768082
DOI: 10.1007/BF00427599.
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.
Post R, Jimerson D, Bunney Jr W, Goodwin F
Psychopharmacology (Berl). 1980; 67(3):297-305.
PMID: 6155678
DOI: 10.1007/BF00431272.
Effect of lithium on central metabolism of 5-hydroxytryptamine.
Poitou P, Guerinot F, Bohuon C
Psychopharmacologia. 1974; 38(1):75-80.
PMID: 4851658
DOI: 10.1007/BF00421289.
Effect of chronic lithium treatment on monoamine metabolism in rat brain.
Schubert J
Psychopharmacologia. 1973; 32(3):301-11.
PMID: 4762238
DOI: 10.1007/BF00422153.
Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats.
Berggren U
J Neural Transm. 1985; 64(3-4):239-50.
PMID: 4086991
DOI: 10.1007/BF01256470.
Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.
VAN KAMMEN D, Docherty J, Marder S, Rosenblatt J, Bunney Jr W
Psychopharmacology (Berl). 1985; 87(1):111-5.
PMID: 3933028
DOI: 10.1007/BF00431789.
Striatal dopamine and motor activity changes observed shortly after lithium administration.
Otero Losada M, Rubio M
Naunyn Schmiedebergs Arch Pharmacol. 1985; 330(3):169-74.
PMID: 2865683
DOI: 10.1007/BF00572429.
The effect of short-term lithium administration on noradrenaline metabolism in the limbic forebrain and hemispheres of rats.
Berggren U
J Neural Transm. 1988; 73(1):71-5.
PMID: 2841421
DOI: 10.1007/BF01244624.
The effect of lithium on urinary MHPG in unipolar and bipolar depressed patients.
Beckmann H, St-Laurent J, Goodwin F
Psychopharmacologia. 1975; 42(3):277-82.
PMID: 1161986
DOI: 10.1007/BF00421268.
Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine.
Furukawa T, Ushizima I, Ono N
Psychopharmacologia. 1975; 42(3):243-8.
PMID: 1161982
DOI: 10.1007/BF00421263.
The role of noradrenaline, dopamine and 5-hydroxytryptamine in the hyperactivity response resulting from the administration of tranylcypramine to rats pretreated with lithium or rubidium.
Judd A, Parker J, Jenner F
Psychopharmacologia. 1975; 42(1):73-7.
PMID: 1153625
DOI: 10.1007/BF00428829.
The effect of lithium on amphetamine-induced locomotor stimulation.
Berggren U, Tallstedt L, Ahlenius S, Engel J
Psychopharmacology (Berl). 1978; 59(1):41-5.
PMID: 100811
DOI: 10.1007/BF00428028.
The effect of chronic lithium administration on dopamine metabolism in rat striatum.
Hesketh J, Nicolaou N, Arbuthnott G, Wright A
Psychopharmacology (Berl). 1978; 56(2):163-6.
PMID: 25454
DOI: 10.1007/BF00431843.
